12th March, 2020
The Company is closely monitoring Government advice relating to the novel coronavirus COVID-19 and has implemented measures designed to reduce the risk of infection for our staff including, but not limited to, a stop on all non-essential business travel.
We have a well-established and stress tested Business Continuity & Disaster Recovery Plan which covers activity required for managing stock and home working for staff. Any social distancing measures recommended by the Government can be implemented quickly with no loss of service for our customers and patients.
The Company is engaging with Government agencies across the UK to provide information on stock levels and we urge customers to follow advice from DHSC not to stockpile essential medicines which in turn will help us to ensure continuity of supply to patients
If you are a hospital on contract with Bowmed Ibisqus and you have any difficulty obtaining contracted medicines from your local AAH Branch please contact us in the first instance on firstname.lastname@example.org or 0845 643 6703
Bowmed Ibisqus Ltd
10th February, 2020
Voriconazole 200mg Vials
Voriconazole 200mg powder for solution for infusion vials have been launched this month in time for the new England Wave 12 contract.
As part of our regulatory obligations we have produced a set of Risk Minimisation Materials to accompany the launch. If you would like to receive a copy of the Risk Minimisation Materials or have any enquiries please contact us directly on +44 (0)845 6436 703 or email email@example.com
This new addition to our UK product range demonstrates continued investment by our group company in this area of specialism. As usual, the product has been listed with AAH and we welcome all enquiries regarding availability.
1st November, 2019
Labetalol 100mg/20ml Ampoules
The launch of Labetalol IV by Bowmed Ibisqus has brought necessary reinforcement of the UK supply chain for this critical hospital medicine following periods of shortage during 2019.
This is the first product to be brought to the UK market following our new distribution partnership with S.A.L.F. S.p.A. For over 90 years S.A.L.F. have brought essential medicines across a variety of therapeutic forms to the Italian market and we are excited to develop this new European partnership in the coming months and years.
This product follows the original and familiar product format of 100mg/20ml and is packaged in clear glass ampoules for ease of visual examination. The ampoules have been affixed with labels in a longitudinal manner so that the product details can be viewed in the same field of vision, in accordance with MHRA Best Practice guidelines. In addition, we have been able to avoid a plastic tray component in favour of a secure recyclable cardboard tray.
The product has been listed with AAH under order code LAB0138K. If you would like to discuss a pricing arrangement or stock availability for Labetalol IV or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us
19th October, 2019
Hope House Chirk Dark Run
On the 19th October Chirk Castle was lit up along with the community of Chirk and surrounding areas during the Hope House Charity 5k Dark Run. Bowmed Ibisqus were delighted to be asked to sponsor this local event that is set to raise over £7,000 of essential funds.
The Dark Run is one of many events organised by the charity that provides support to families in need of Palliative care at home, in the community and at Hope House Oswestry and Ty Gobaith.
Hope House is a local charity founded by Caroline and Roger Peachey on March 4th, 1991 following the death of their third child Hope. Hope House work hard to ensure that children affected by life limiting conditions and their families can have the best possible quality of life with access to specialist care and bereavement support, when and where they need it.
The charity is working hard to raise £6.5 million this year and we wish them every success in reaching their goal!